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ABSTRACT
When an oligonucleotide containing a 1,3-(G,G)-transplatin cross-link at a GNG site (N represents a
C, T, A or U residue) is paired with its complementary strand, the intrastrand adduct rearranges into an
interstrand cross-link, resulting in the covalent attachment of both strands. Here, we have studied
theinfluence of the inert ligands of the platinum(II) complex and of the nucleotide residues in the vicinity of
the adduct on the rearrangement reaction. Dramatic effects on the linkage isomerization rate could be
observed with half-lives of the intrastrand adducts ranging from a few minutes to over 50 hours at 37C. The
results are analyzed in relation with the mechanism of rearrangement of the 1,3-intrastrand adducts into
interstrand cross-links. The relevance ofplatinated oligonucleotides as potent and specific drugs is discussed.
INTRODUCTION
Many enzymes rely on metal cofactors to perform catalysis. It is the case for protein enzymes as
well as DNA and RNA enzymes, the so-called ribozymes (1, 2). Several natural ribozymes (e.g. group I or
group II introns) are not true enzymes since they are chemically modified during the very reactions they
trigger. However, it is often possible to design trans-acting molecular systems derived from these natural
ribozymes, in which one component acts as atrue enzyme, not altered by the reaction and capable to catalyze
multiple rounds of the same reaction. Ribozymes have a great potential in biotechnology and medecine and
new catalytic RNA or DNA molecules have been discovered by in vitro selection methods. Most of these
synthetic dbozymes utilize metal cofactors such as Mg2/, Ca
2+ or Pb
2/ (3).
The reaction between trans-diamminedichloroplatinum(II) (transplatin) (Figure 1) and single-
stranded oligonucleotides containing a GNG sequence yields trans-{Pt(NH3)2[(GNG)..GN7,GN7]}
intrastrand cross-links (1,3-(G,G)-intrastrand cross-links). These are usually stable within single-stranded
oligonucleotides, with the exception of adducts formed at CGNG sites (4, 5). By contrast, instability appears
tobe the general rule within the duplexes formed by the platinated oligonucleotides and their complementary
DNA or RNA strands: 1,3-(G,G)-transplatin intrastrand cross-links rearrange into interstrand cross-links (6-
8). In this reaction, by analogy with natural ribozymes, the nucleic acid double helix may be considered as a
catalytic molecule (9). It should then be possible to split the platinated duplex into several individual
components among which one tram-acting molecule is a true enzyme (for a hint at what could be done, see
ref. (10)). Remarkably, this would represent the first example of a ribozyme in which the metal is not merely
a cofactor but is in fact the substrate which undergoes the chemical reaction. In the present study, we have
focused our attention on the molecular environnement of the platinum(II) moiety. We have characterized the
influence on the rearrangement kinetics of its inert ligands as well as the role of the oligonucleotide sequence
in its vicinity. Collectively, the results suggest that chemical bond strain and proper orbital steering, two
factors often essential for enzymatic reactions, are important in the rearrangement reaction. In addition, the
results also provide valuable information to develop further the use of platinated oligonucleotides as specific
molecular tools in biotechnology and medecine (8, 11).
MATERIALS AND METHODS
Materials. Oligodeoxyribonucleotides and oligo(2’-O-R-ribonucleotide)s from Eurogentec (Belgium) were
purified by strong anion exchange chromatography, as described (5,6). The purified oligoribonucleotides
were from Genset (France). T4 polynucleotide kinase was purchased from New England Biolabs (U.K.),
[32p]-,ATP from Amersham Pharmacia Biotech, transplatin from Johnson-Mattey (U.K.), while platinum(II)
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derivatives () to (4) (Figure 1) were kin<iy pr<vi,d<-d
Germany). All other chemicals were from Merck.
Platination of the oligonucleotides.
were prepared and purified as described
pertbrmed as described (6,11).
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nucleophile) within duplexes well as confomtakmal a.mplir,a of he pa.atcd double helices may’ be
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Figure 2" Conversion of 1,3-(G,G)-intrastrand adduets into interstrand cross-links within double-stranded
oligonucleotides. A representative gel is shown. The oligo(2’-O-Allylribonucleotide) 5’-
CUCCUCUGUGUCUCCUU-3’ containing a single 1,3-(G,G)-intrastrand cross-link (chelated residues are in
bold font) was paired with the 5’-AAGGAGA[ ]AGAGGAGA-3’ RNA strands (where corresponds to the
the AU, UA or AA doublet as indicated above the corresponding lanes). At various times (indicated in
minutes above each lane) during incubation at 37C in 150 mM NaCIO4, 5mM phosphate buffer and 0.2mM
EDTA, pH 7.5, aliquots were removed and analyzed on a denaturing 24% polyacrylamide gel. The lane U
refers to the 5’-end labeled single-stranded 5’-AAGGAGAUAAGAGGAGA-3’ oligoribonucleotide.
Table 1:
.duplexes
Platinated
strand
a
(5’--,3’)
Half-lives (in hours) of the 1,3-(G,G)-transplatin intrastrand cross-links within DNA.DNA
TCTCT ACTCA
Complementary strand
b
(5’--3’)
ACTCC ACACC ACACA ATATA ACATA AATCA ACTTA
TGTGT 3 12 15 > 18 8 14
AGAGA 1.6
GGTGT 1.2 4
TG(cz)GT 1.5 8
TGAGT 6 24
a Platinated strands were 20-mer of identical sequence except for the 5 central nucleotides as indicated in the
table, c3 represents a propylene moiety replacing the central A or T residue. Platinated G residues are in bold.
b The five central nucleotides of the 20-nucleotide long complementary strands facing the 1,3-(G,G)-
intrastrand cross-link are shown.
From ref. (6,7)
In a search for factors or conditions that may further accelerate the linkage isomerization and thus
make platinated oligonucleotides even more versatile tools for applications in biology (8,11), we have studied
the kinetic influence of the platinum(II) inert ligands. Oligonucleotides were reacted with transplatin or
platinum(II) complexes (1_) to () (figure 1) to form the respective 1,3-(G,G)-intrastrand cross-links at the
unique GTG site. The linkage isomerization reaction within the d(TGTGT).d(ACACA) sequence was
monitored as described above. Results are given in table 2.
Replacement ofthe transplatin moiety by any of the derivatives () to (4_) has a dramatic effect on the
rearrangement reaction(table 2). While compound 2() slows down the reaction by at least a factor 4, the other
derivatives increase the rate of rearrangement 6 to 20 times, the most efficient being compound I(.D. The
derivative () has two bulky ligands which may impair proper approach and orientation of reactants along the
reaction pathway. Similar observations were made with other platinum(II) complexes having sterically
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demanding inert ligands such as pyridines or imino-ethers (data not shown). It is interesting to note, however,
that compounds (), 3() and () also have bulkier inert ligands than transplatin but still favor the linkage
isomerization reaction. Thus, the platinated duplex is able to accommodate these ligands within a productive
conformation. In this respect, the flexibility of the inert ligands (as for the linear alkylamines of compounds
(1_), () and ()) may be an important factor.
Table 2: Rearrangement of 1,3-(G,G)-intrastrand cross-links of various transplatin derivatives into
interstrand cross-links within 20-mer DNA.DNA duplexes. 0fcentral sequence d(.TGTGT):d(ACA..CA)
Cross-linking agent
transplatin (d.) 2() (3_) 4(.)
Haif-life (h) 12
a 0.55 > 50 2
From ref..(6)
Compound 1( appeared the most efficient transplatin derivative. To further evaluate its positive
effect on the rearrangement kinetics, several other platinated oligonucleotides were prepared. The reactivities
of the 1,3-(G,G)-intrastrand cross-links within DNA.DNA duplexes were then evaluated and compared for
transplatin and compound (1_) (Tables 3 and 4).
Table 3: Half-lives (in hours) of 1,3-intrastrand cross-links of transplatin or complex (1) within DNA.DNA
duplexes
Complementary
strand
b
(5’--,3’)
Platinated strand
a
(5’---3’)
TGAGT TGTGT TG (c3)GT TGAIT
ACACA
ACTCA
transplatin () transplatin () transplatin (1_) transplatin
24 12’ 0.55 8 0.5
6 0.3 3 0.25 1.5 0.15 20
Platinated strands were 20-mer of identical sequence except for the 5 central nucleotides as indicated in the
table, c3 represents a propylene moiety. Platinated G residues are shown in bold.
b The five central nucleotides of the 20-nucleotide long complementary strands facing the 1,3-intrastrand
cross-links are shown.
From ref. (6)
Table 4: Rearrangement of 1,3-intrastrand adducts of complex (].) into interstrand cross-links within
DNA.DNA duplexes
Platinated strand (5’---}3’)
TGTGT TGTIT TGAGT TGAIT TITIT TG (c3)GT TG (C2) IT TG(c4) IT
Half-life 0.25 1.25 0.3 1.25 0.15 2.5 2.5
Platinated strands were 20-mer of identical sequences except for the 5 central nucleotides as indicated in the
table, c2, c3 and c4 represent ethylene, propylene and butylene residues, respectively. Platinated G or I residues
are shown in bold. In all cases, the complementary strand contained the central d(ACTCA) sequence facing
the cross-link.
Within all tested sequences, replacement of the transplatin moiety by derivative (1_) increases the
reaction rate 10 to 20 fold. In several instances, the half-life of the 1,3-intrastrand adduct is only a few
minutes at 37C. The kinetic effect of the residues in the vicinity of the platinum(H) moiety appears reduced
in the case of compound as compared to transplatin. One exception to this rule concerns the platinated 3’-
G residue: when it is replaced by an inosine, the linkage isomerization reaction is significantly slowed down
(table 4). This result reveals that the Y-G-NH2 moiety is important for the reaction kinetics; it is likely
involved in hydrogen-bonding with the complementary C residue, whose replacement by a T residue also
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slows the reaction (table 1). Such imeractions could contribute primarily to the positioning of the reactants
rather than to a large increase of ring strain. Indeed, replacement of the central N residue within a GNI
sequence by an ethylene or butylene moiety does not havea dramatic effect on the reaction (table 4).
Finally, we studied the rearrangement of 1,3-(G,G)-intrastrand cross-links of complex 1(1.) into
interstrand cross-links within (2’-O-MethyI-RNA).RNA hybrids. In the case of transplatin, the reaction can
be extremely fast within certain sequences and we have successfully tested platinated oligo(2’-O-Methyl-
ribonucleotide)s as antisense agents in in vitro and ex vivo assays (8,11). Considering our previous data (8), a
significant acceleration of the linkage isomerization reaction for a broader range of target sequences could
represent an important improvement for antisense applications. However, replacement of transplatin by
derivative l(.l.) within the platinated (2’-O-MethyI-RNA).RNA hybrids has very little effect on the slower
linkage isomerization reactions (table 5). Only within the (2’-O-Methyl-r(UGUGU)).r(AUGA) hybrid is the
rearrangement reaction 10-times faster.
Table 5: Half-lives (in hours) of the 1,3-(G,G)-intrastrand cross-links of transplatin or complex (1_) within
(2’-O-MethyI-RNA).RNA hybrids
complementary strand (5’---,3’)
ACACA ACAUA AUGCA AUCCA AGAA AAAA AAUA AUGA
transplatin 3
b 4
b 0.5 0.5
b 0.5
b > 24
b > 24
(1_) 2 4 0.6 0.3 2 > 24 2.25
a In all cases, the platinated strand (top strand) was a $-mer oligo(2’-O-Methyl-ribonucleotide) containing
the UGUGU central sequence.
b From ref.(8)
DISCUSSION
Within platinated double-stranded oligodeoxyribonucleotides containing the d(GNG).d(CN’C)
sequence (N and N’ are A, T or C), 1,3-intrastrand adducts rearrange into thermodynamically stable
interstrand cross-links (6,7). These interstrand cross-links are formed between the 5’-G of the GNG motif and
its complementary C residue. When N’ A, a second minor cross-link is also formed between the 5’-G and
the A residue. Within DNA.DNA duplexes, the linkage isomerization reaction occurs within all the
sequences that were studied but the reaction rates can be dramatically different (1 < :/2 < 50h, at 37C). Not
all residues in the vicinity of the adduct are of equivalent influence. For instance, the base and sugar of the
central N residue have little effect on the kinetics and N can even be replaced by a propylene moiety (table 1;
ref. (7)). By contrast, the nature of the opposite N’ residue can significantly alter the reaction rate (table 1).
The rearrangement is about five times slower when N’ is a purine as compared to a pyrimidine. A purine on
the 5’-edge of the intrastrand cross-link (as in the GGTGT sequence) also favors reaction kinetics (table 1).
Another parameter that can greatly interfere with the rearrangement reaction is the nature of the platinum(II)
inert ligands. Significant variations of theintrastrand cross-link half-lives (up to two orders of magnitude)
were observed for various bulky inert ligands (table 2); substitution of the NH3 ligands of transplatin by
linear alkylamines can lead to linkage isomerization reactions that are complete in less than one hour at 37C.
Although all tested transplatin derivatives have two identical inert ligands (figure 1), it could be of interest to
assess the effect ofasymetric platinum(II) complexes on the linkage isomerization reaction.
The local oligonucleotide sequence at the site of the 1,3-cross-link can also drastically change the
reaction rate within platinated DNA.RNA or (2’-O-R-RNA).RNA hybrids (R being a methyl or allyl group).
However, in such hybrids, the maximal effects coincide with the deletion of one of the residues facing the
intrastrand cross-link (figure 2; ref.(8)). The permutation of the nucleotides facing the intrastrand cross-link
can also have a strong effect on the reaction (figure 2; (8)). On the other hand, replacement of the transplatin
moiety by derivative only marginally improves the rearrangement kinetics within platinated (2’-O-R-
RNA).RNA hybrids (table 5). Finally, it is to be noted that, in the final product, the cross-linked atom within
the RNA complementary strand is predominantly a A-N1 rather than a C-N3 (8).
In order to rationalize these data, one should assume that the rearrangement reaction proceeds
through direct nucleophilic attack (SN2 mechanism; ref. (9)) and should consider the following scheme:
43R. Dalbis-Tran, M. Leng and M. Boudvillain Oligonucleotides Modified with Transplatin
Derivatives Fast and Efficient Metalloribozymes
O) (2) (3)
A(Pt) + B A(Pt).B [A(Pt).BI A-Pt-B
where A(Pt) represents the top strand containing a 1,3-intrastrand adduct, B is the bottom strand, A(Pt).B is
the platinated duplex in a non-productive or productive (*) conformation and A-Pt-B is the duplex containing
an interstrand cross-link.
The 1,3-intrastrand adduct is usually stable within the single-stranded A(Pt) species. The formation
of the A(Pt).B double helix (step 1), which brings the reactants in close proximity, is therefore critical to the
rearrangement reaction. As is the case for theassembly of trans-acting ribozymes, the limitation for step is
likely the rate of diffusion of oligonucleotides within aqueous media, close to 10s M.sat 37C (13). If step
was the rate-limiting step of the linkage isomerization reaction, the half-life of the intrastrand cross-link
within the duplex would be about 10
"4
S (for micromolar solutions of oligonucleotides), several orders of
magnitude lower than our experimental values (see tables 1-5). Thus, the rate-limiting step for
therearrangement reaction is probably subsequent to the annealing of both strands. All collected data suggest
that an important factor for the reaction is the respective orientation of reactants rather than a mere increase
in their local effective concentrations. However, the optimal set-up of reactants is not necessarily obtained
right after pairing (step 1) and a potentially rate-limiting conformational change (step 2) may be required to
properly align the reactive entities. Therefore, conformational sampling of the platinated duplex or hybrid
could also be a major kinetic factor. In the rigid A-form helices adopted by (2’-O-R-RNA).RNA hybrids (14),
reactants would have to be ideally positioned right after pairing for the reaction to proceed quickly and
efficiently. This is likely the case for the platinated (2’-O-R-r(UGUGU)).r(AUAA) hybrids in which the
isomerization is extremely fast (figure 2; ref. (8)) and the chemical step (step 3) is potentially rate-limiting.
Within suchrigid hybrids, substitution of the platinum(II) inert NH3 ligands by bulkier but still flexible
alkylamines should have only limited consequences on conformation and therefore little kinetic effect (table
5; ref. (11)). By contrast, permutation of the two residues facing the intrastrand cross-link displaces the RNA
nucleophile a few angstroms away from the platinum(II) center, which dramatically slows down the
rearrangement reaction (figure 2; ref. (8)). It seems reasonnableto assume that the rigid hybrid cannot easily
adjust to the new set-up of reactants. The situation appears different for DNA.DNA duplexes, whose
flexibility allows various nucleophiles within the complementary strand to react with the platinum(II)
centerto form interstrand cross-links (table 1; ref. (6)). It is tempting to speculate that, in the case of
DNA.DNA duplexes, the acceleration of the linkage isomerization reaction upon replacement of the
transplatin moiety by derivative (1_), () or (4_) is due to ligand-induced sterical reduction of conformational
sampling and locking of the duplex central region into conformations that insure a productive positioning of
reactants.
Another factor potentially important for the linkage isomerization reaction is bond strain within the
1,3-intrastrand cross-link. Although it is difficult to experimentally weigh its role against those of other
parameters, several lines of evidence suggest that bond strain may be a non-negligible driving force of the
isomerization reaction. For instance, within single-stranded oligonucleotides containing a d(CGNG)
sequence, 1,3-(G,G)-intrastrand cross-links slowly evolve into less constrained, thermodynamically favored,
1,4-(C,G)-intrastrand adducts (4,5). Moreover, the Pt-G bond that is broken during the linkage isomerization
reactions depends on whether the oligonucleotides are single- or double-stranded (5,6). It is possible that
restriction of conformational freedom resulting from annealing with the complementary strand and/or from
the approach of the nucleophile transfers a large part of the strain due to the platinum(II) chelation and to
sterical crowding into a single chemical bond concomitantly to the productive alignment of reactants. This
would result in lowering the activation energy barrier to the linkage isomerization reactions in a mechanism
similar to enzymatic reactions (15-17).
Oligonucleotides containing 1,3-intrastrand adducts which spontaneously and specifically cross-link
complementary RNA or DNA targets can be useful molecular tools in biology and medicine. In fact, we have
previously demonstrated that platinated oligo(2’-O-methylribonucleotide)s are efficient antisense agents that
specifically inhibit the expression of their target gene, in vitro or in cultured cells (8,11). A key factor to the
successful use of platinated oligonucleotides is the rate of the rearrangement reaction. Within complex
biological media, a fast cross-linking reaction is required so that the oligonucleotide has a high probability to
covalently associate with its target during their rare bimolecular uncounters and before cellular machineries
such as highly processive polymerases trigger their dissociation. In this paper, we present data that should
facilitate the design of platinated oligonucleotides that quickly and efficiently cross-link a broader array of
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RNA and DNA targets. By manipulating the nature of the platinum(II) ligands, the sequence and the
backbone chemistry of platinated oligonucleotides, it should be possible to obtain fast rearrangement
reactions within a variety of sequences. Adapting the SELEX method (3) to this task could result in a cost-
effective, high-throughput screening of newand specific platinum(II)obased drugs. Then, platinated
oligonucleotides that efficiently cross-link to non nucleic acid targets, such as cellular proteins, may also be
evolved from large pools ofrandomized molecules.
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